Skip to main content
Year archive

Zelluna ASA — 2019 filings

All 33 regulatory filings released by Zelluna ASA (ULTI) in 2019, sourced directly from the official regulator.

33 Filings
2019 Period
2019 filings (33)
Filing Released Lang
Ultimovacs ASA – With support from Bristol-Myers Squibb and Ultimovacs, UV1 will be tested in a large, randomized combination trial in mesothelioma initiated by Oslo University Hospital
Regulatory Filings
2019-12-13 English
Ultimovacs ASA – Poster presentation at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Regulatory Filings
2019-12-04 English
Ultimovacs ASA: Third quarter 2019 result presentation
Interim / Quarterly Report Q3 2019
2019-11-14 English
Ultimovacs ASA: Third quarter 2019 result presentation
Investor Presentation
2019-11-14 English
Ultimovacs ASA: Third quarter 2019 result presentation
Report Publication Announcement
2019-11-14 English
Ultimovacs ASA – LONG TERM RESULTS FROM UV1 CLINICAL STUDY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Earnings Release Q4 2019
2019-11-09 English
Ultimovacs ASA: Invitation to third quarter 2019 result presentation
Report Publication Announcement
2019-11-05 English
Ultimovacs ASA – Poster presentation at the 2019 Annual Meeting of Society for Immunotherapy of Cancer (SITC)
Report Publication Announcement
2019-10-30 English
Ultimovacs ASA - Start of inclusion of additional group of 10 patients
Regulatory Filings
2019-10-01 English
Ultimovacs ASA: First half 2019 results
Interim / Quarterly Report H1 2019
2019-08-21 Norwegian
Ultimovacs ASA: First half 2019 results
Earnings Release H1 2019
2019-08-21 Norwegian
Ultimovacs ASA: First half 2019 results
Earnings Release H1 2019
2019-08-21 English
Ultimovacs ASA: Invitation to first half 2019 result presentation
Report Publication Announcement
2019-08-20 English
Major Shareholder Disclosure Notification - ULTIMOVACS ASA
Declaration of Voting Results & Voting Rights Announcements
2019-08-06 English
Major Shareholder Disclosure Notification - ULTIMOVACS ASA
Major Shareholding Notification
2019-08-06 English
Ultimovacs ASA – End of stabilisation
Share Issue/Capital Change
2019-07-03 English
Ultimovacs ASA - European patent approval for UV1
Regulatory Filings
2019-06-25 English
Ultimovacs ASA - Share Option Program
Remuneration Information
2019-06-03 English
Oslo Børs - Ultimovacs ASA - Nytt selskap til notering / New security will be listed 03.06.2019
Regulatory Filings
2019-06-03 Norwegian
Ultimovacs ASA – Stabilisation notice
Share Issue/Capital Change
2019-06-03 English
Oslo Børs - Ultimovacs ASA - Nytt selskap til notering / New security will be listed 03.06.2019
Delisting Announcement
2019-05-31 Norwegian
Ultimovacs ASA – New registered share capital
Share Issue/Capital Change
2019-05-31 English
Ultimovacs ASA – Allocations to primary insiders
Share Issue/Capital Change
2019-05-29 English
Ultimovacs ASA – Allocations to primary insiders
Share Issue/Capital Change
2019-05-29 English
Ultimovacs ASA – Successful completion of initial public offering
Share Issue/Capital Change
2019-05-29 English
Ultimovacs ASA – Last day of the bookbuilding and application period in the IPO
Share Issue/Capital Change
2019-05-29 English
Financial calendar
Report Publication Announcement
2019-05-27 English
Oslo Børs godkjenner Ultimovacs ASA for notering på Oslo Børs
Regulatory Filings
2019-05-24 Norwegian
Ultimovacs ASA – Applications by primary insiders
Regulatory Filings
2019-05-23 English
Oslo Børs - Received application for listing - Ultimovacs ASA
Regulatory Filings
2019-05-22 English
Oslo Børs - Received application for listing - Ultimovacs ASA
Regulatory Filings
2019-05-21 English
Ultimovacs ASA – Approval and publication of the prospectus and commencement of the bookbuilding and the application period
Capital/Financing Update
2019-05-21 English
Ultimovacs ASA – Underwritten initial public offering on the Oslo Stock Exchange
Capital/Financing Update
2019-05-20 English